Publication Name	World Journal of Diabetes
Manuscript ID	82680
Country	Japan

Received	2022-12-28 03:10
Peer-Review Started	2022-12-28 03:11
To Make the First Decision
Return for Revision	2023-01-05 08:47
Revised	2023-01-13 07:40
Second Decision	2023-02-08 03:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-02-09 00:42
Articles in Press	2023-02-09 00:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-09 10:36
Publish the Manuscript Online	2023-03-15 15:41

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes
Manuscript Source	Invited Manuscript
All Author List	Hiroshi Nomoto
ORCID	Author(s) ORCID Number Hiroshi Nomoto http://orcid.org/0000-0003-0713-221X
Funding Agency and Grant Number
Corresponding Author	Hiroshi Nomoto, MD, PhD, Assistant Professor, Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan. hnomoto@med.hokudai.ac.jp
Key Words	Clinical trial; Diabetes mellitus, type 2; Glucagon-like peptide-1 receptor; Glycemic control; Insulin, long-acting; Quality of life
Core Tip	Fixed-ratio combination injections comprising basal insulin and glucagon-like peptide-1 receptor agonists are now available, and their efficacy for glycemic control has been demonstrated in several phase II/III trials. These injections appear to be useful based on the trial data, but real-world clinical evidence regarding the use of these compounds is limited. In this review, the clinical evidence derived from phase III and real-world clinical studies regarding the glycemic control of and other outcomes in participants with type 2 diabetes is summarized.
Publish Date	2023-03-15 15:41
Citation	Nomoto H. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes. World J Diabetes 2023; 14(3): 188-197
URL	https://www.wjgnet.com/1948-9358/full/v14/i3/188.htm
DOI	https://dx.doi.org/10.4239/wjd.v14.i3.188

Full Article (PDF)	WJD-14-188.pdf
Full Article (Word)	WJD-14-188.docx
Manuscript File	82680_Auto_Edited-LM.docx
Answering Reviewers	82680-Answering reviewers.pdf
Audio Core Tip	82680-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	82680-Conflict-of-interest statement.pdf
Copyright License Agreement	82680-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	82680-Language certificate.pdf
Peer-review Report	82680-Peer-review(s).pdf
Scientific Misconduct Check	82680-Bing-Fan JR-2.png
Scientific Editor Work List	82680-Scientific editor work list.pdf